AKER BIOMARINE ASA(OSL:AKBM) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to AKBM. AKBM was compared to 57 industry peers in the Food Products industry. AKBM has only an average score on both its financial health and profitability. AKBM is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AKBM had negative earnings in the past year.

AKBM had a positive operating cash flow in the past year.

In multiple years AKBM reported negative net income over the last 5 years.

AKBM had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

AKBM's Return On Assets of 46.54% is amongst the best of the industry. AKBM outperforms 100.00% of its industry peers.

AKBM has a better Return On Equity (103.68%) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	46.54%
ROE	103.68%
ROIC	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 78.80%, AKBM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

Looking at the Gross Margin, with a value of 31.82%, AKBM is in line with its industry, outperforming 40.35% of the companies in the same industry.

In the last couple of years the Gross Margin of AKBM has declined.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	78.8%
GM	31.82%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AKBM does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AKBM has about the same amount of shares outstanding.

AKBM has about the same amout of shares outstanding than it did 5 years ago.

The debt/assets ratio for AKBM has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.80, we must say that AKBM is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.80, AKBM is doing worse than 85.96% of the companies in the same industry.

AKBM has a Debt/Equity ratio of 0.81. This is a neutral value indicating AKBM is somewhat dependend on debt financing.

With a Debt to Equity ratio value of 0.81, AKBM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF	N/A
Altman-Z	0.8

ROIC/WACCN/A

WACC8%

2.3 Liquidity

A Current Ratio of 3.79 indicates that AKBM has no problem at all paying its short term obligations.

With an excellent Current ratio value of 3.79, AKBM belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.

A Quick Ratio of 1.98 indicates that AKBM should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.98, AKBM belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.79
Quick Ratio	1.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AKBM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -157.14%.

AKBM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.76%.

Measured over the past years, AKBM shows a quite strong growth in Revenue. The Revenue has been growing by 16.81% on average per year.

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-144.44%

Revenue 1Y (TTM)-31.76%

Revenue growth 3Y5.13%

Revenue growth 5Y16.81%

Sales Q2Q%-37.27%

3.2 Future

Based on estimates for the next years, AKBM will show a very strong growth in Earnings Per Share. The EPS will grow by 91.59% on average per year.

The Revenue is expected to grow by 12.35% on average over the next years. This is quite good.

EPS Next Y227.5%

EPS Next 2Y107.24%

EPS Next 3Y103.08%

EPS Next 5Y91.59%

Revenue Next Year-22.73%

Revenue Next 2Y-16.1%

Revenue Next 3Y-7.93%

Revenue Next 5Y12.35%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AKBM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 55.66, which means the current valuation is very expensive for AKBM.

73.68% of the companies in the same industry are cheaper than AKBM, based on the Price/Forward Earnings ratio.

AKBM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.74.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	55.66

4.2 Price Multiples

AKBM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKBM is more expensive than 78.95% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.47

4.3 Compensation for Growth

AKBM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

AKBM's earnings are expected to grow with 103.08% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y107.24%

EPS Next 3Y103.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AKBM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (5/6/2025, 4:19:26 PM)

53.1

+0.4 (+0.76%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)04-30 2025-04-30

Earnings (Next)07-11 2025-07-11

Inst Owners8.8%

Inst Owner ChangeN/A

Ins Owners3.14%

Ins Owner ChangeN/A

Market Cap4.66B

Analysts82.22

Price Target79.05 (48.87%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend44.13

Dividend Growth(5Y)N/A

DP206.99%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-281.86%

Min EPS beat(2)-684.31%

Max EPS beat(2)120.59%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-10.8%

Min Revenue beat(2)-13.17%

Max Revenue beat(2)-8.42%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)4.03%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-30.77%

EPS NY rev (3m)-40%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.42%

Revenue NY rev (3m)-1.65%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	55.66
P/S	1.96
P/FCF	N/A
P/OCF	36.73
P/B	2.58
P/tB	8.87
EV/EBITDA	14.47

EPS(TTM)-0.42

EYN/A

EPS(NY)0.95

Fwd EY1.8%

FCF(TTM)-1.29

FCFYN/A

OCF(TTM)1.45

OCFY2.72%

SpS27.11

BVpS20.61

TBVpS5.98

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	46.54%
ROE	103.68%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	78.8%
GM	31.82%
FCFM	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

F-Score6

Asset Turnover0.59

Health

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF	N/A
Debt/EBITDA	3.52
Cap/Depr	48.33%
Cap/Sales	10.1%
Interest Coverage	N/A
Cash Conversion	30.58%
Profit Quality	N/A
Current Ratio	3.79
Quick Ratio	1.98
Altman-Z	0.8

F-Score6

WACC8%

ROIC/WACCN/A

Cap/Depr(3y)77.43%

Cap/Depr(5y)88.04%

Cap/Sales(3y)14.31%

Cap/Sales(5y)16.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-144.44%

EPS Next Y227.5%

EPS Next 2Y107.24%

EPS Next 3Y103.08%

EPS Next 5Y91.59%

Revenue 1Y (TTM)-31.76%

Revenue growth 3Y5.13%

Revenue growth 5Y16.81%

Sales Q2Q%-37.27%

Revenue Next Year-22.73%

Revenue Next 2Y-16.1%

Revenue Next 3Y-7.93%

Revenue Next 5Y12.35%

EBIT growth 1Y-249.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year204.17%

EBIT Next 3Y72.41%

EBIT Next 5YN/A

FCF growth 1Y-473.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-74.26%

OCF growth 3Y155.79%

OCF growth 5Y-0.17%

AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens